Replies to post #71417 on Ariad Pharmaceuticals Inc fka ARIA

[flexinvester]

Not to belabor this discussion but I see it going one of two ways:

1. Your illustration of IDIX where it jumped without warning on a BO

2. Allowing the shorts to get out and taking it to a mezzanine level of $9 -$12 (where we were in Sept 2015) and then doing the BO. In that scenario, it could do a double or triple with the result of getting into the $20's. Where we are now ($4-$6), it is tougher to "sell" a 4X or 5X and justify that type of premium to a buyer. Most of all, Denner knows what he is doing and how to maximize the outcome as he knows the industry and players very, very well.

Thanks again for the conversation about this and always interested in your take.